Core Points - The company held its 8th meeting of the 12th Board of Directors on November 21, 2025, to discuss several internal equity transfers and structural adjustments aimed at optimizing management efficiency [1][2][24]. Group 1: Internal Equity Transfers - The company approved the internal transfer of 100% equity of its subsidiary, Guoxin Health Guarantee Service (Guangdong) Co., Ltd., from Guoxin Health Guarantee Service Co., Ltd. to the company itself [2][10]. - Additionally, 80% equity of Hainan Weihong Pharmaceutical E-commerce Co., Ltd. was transferred from Hainan Haihong Investment Consulting Co., Ltd. to the company [2][10]. - The voting results for these proposals were unanimous, with 9 votes in favor and no opposition [3][5]. Group 2: Changes in Shareholding Structure - The company also approved the transfer of 100% equity of Beijing Haixie Zhikang Technology Development Co., Ltd. from Hainan Haihong Investment Consulting Co., Ltd. to the company [4][25]. - This transfer is part of the company's strategy to streamline its internal management structure and will not affect the consolidated financial statements or the equity interests in subsidiaries [25][31]. Group 3: Non-Public Agreement for Equity Transfer - The company plans to acquire 100% equity of Beijing Yihong Yitong Technology Service Co., Ltd. from its subsidiary, Yuchuang Investment (Hong Kong) Co., Ltd., for a transaction price of 345,523,290.56 yuan [6][36]. - This acquisition is also aimed at optimizing the internal management structure and will not impact the company's consolidated financial statements [36][41].

Core Viewpoint - Guoxin Health (000503.SZ) is optimizing its internal management structure by transferring 100% equity of Beijing Haixie Zhikang Technology Development Co., Ltd. from its wholly-owned subsidiary Hainan Haihong Investment Consulting Co., Ltd. to itself, aiming to enhance management efficiency [1] Group 1: Equity Transfer Details - The equity transfer is a part of the internal equity structure adjustment and will not affect the company's consolidated financial statements or its equity stake in the subsidiary [1] - After the completion of the equity transfer, Beijing Haixie will continue to be included in the company's consolidated financial statements as it is one of the implementation entities for the company's fundraising project "Marketing Network Upgrade Construction Project" [1]

Core Viewpoint - Guoxin Health (000503.SZ) is optimizing its internal management structure by transferring 100% equity of Guoxin Health Guarantee Service (Guangdong) Co., Ltd. and 80% equity of Hainan Weihong Pharmaceutical E-commerce Co., Ltd. to enhance management efficiency and streamline hierarchy [1] Group 1 - Guoxin Health's wholly-owned subsidiary, Guoxin Health Guarantee Service Co., Ltd., will transfer its 100% equity in Guoxin Health Guarantee Service (Guangdong) Co., Ltd. to Guoxin Health [1] - The wholly-owned subsidiary Hainan Haihong Investment Consulting Co., Ltd. will transfer 80% of its shares in Hainan Weihong Pharmaceutical E-commerce Co., Ltd. to Guoxin Health [1] - After the completion of these equity transfers, Guoxin Health will directly hold 100% equity in both Guoxin Health Guarantee Service (Guangdong) and Hainan Weihong [1] - The equity changes are part of an internal restructuring and will not affect the consolidated financial statements or the equity interests in subsidiaries [1]

Core Viewpoint - The company is transferring 100% equity of Beijing Yihong Medical Technology Service Co., Ltd. to itself through its wholly-owned subsidiary, Yuchuang Investment (Hong Kong) Co., Ltd., for a transaction price of 346 million yuan [1] Group 1 - The transaction will result in the company directly holding 100% equity of Yihong Medical after the transfer is completed [1] - This equity change is part of an internal restructuring of the company's and its subsidiary's shareholding structure [1]

Core Viewpoint - Liard has merged its two business segments, cultural tourism and night economy, into a single segment called "Cultural Tourism Night Tour" to better align with its development strategy and maximize synergies between the two segments [1] Group 1: Business Restructuring - The company plans to transfer 100% equity of Liard Smart Technology Group Co., Ltd. to its wholly-owned subsidiary, Guangzhou Lifeng Cultural Technology Co., Ltd., through a non-compensatory transfer [1] - After the transfer, Lifeng Cultural will hold 100% equity of Liard Smart Technology, while the company will remain the actual controller of Liard Smart Technology [1] - This transaction is an internal equity structure adjustment, and the company's consolidated financial statement scope will not change [1] Group 2: Strategic Objectives - The restructuring aims to optimize the group management model and improve the operational efficiency of subsidiaries [1] - The board of directors has authorized the management team to organize and handle the relevant matters of this equity restructuring [1]